Corticosteroid use in pregnancy for maternal IBD associated with an increased risk of preterm delivery

Researchers from Odense University Hospital in Denmark have published the results of a population-based observational comparative cohort study investigating pregnancy and infant outcomes following maternal corticosteroid use to treat inflammatory bowel disease (IBD). More information available here.